Urothelial Cancer
C6461006: AN INTERVENTIONAL PHASE 1b/2, OPEN-LABEL STUDY TO INVESTIGATE THE SAFETY, ANTITUMOR ACTIVITY, AND PHARMACOKINETICS OF PF08634404 MONOTHERAPY OR IN COMBINATION WITH ENFORTUMAB VEDOTIN IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER
- Details
ClinicalTrials.gov ID:
NCT07421700
Diagnosis Type:
NA
USOR Number:
- Address
,
P: